Ionix Pharmaceuticals Increases Efficiency with ActivityBase from IDBS

IDBS, provider of integrated data management, analysis and decision-making software for biopharmaceutical discovery research, announced today that Ionix Pharmaceuticals Ltd of Cambridge, UK, has implemented IDBS’ ActivityBase suite. Ionix Pharmaceuticals is a leading research-based drug discovery organisation focusing on the discovery of novel analgesics for treatment of acute and chronic pain conditions. Ionix Pharmaceuticals will deploy ActivityBase to capture, manage and integrate biological, chemical and inventory data.

The company has implemented the ActivityBase software suite to cover its work process from registration of novel molecules, compound management using the ActivityBase Inventory Management module (AIM), and entry and manipulation of data from screening and secondary assays. Efficiency has been significantly enhanced by using the automation facilities of ActivityBase, which allow real-time screening data entry and analysis. The integrated solution offered by ActivityBase provides a single repository of information for both chemists and biologists.

In addition, Ionix will use IDBS’ ChemXtra data cartridge to facilitate development and integration of custom workflow management processes that are chemically-aware.

Dr. Iain James, Director of Drug Discovery at Ionix Pharmaceuticals commented: “We are impressed by the potential capabilities of ActivityBase and look forward to working with IDBS on this project.”

Neil Kipling, IDBS’ Chairman and CEO commented: “We are delighted to be helping Ionix Pharmaceuticals put in place an extensible and sustainable informatics platform encompassing chemistry, biology and inventory.”

About Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals, based in Cambridge UK, is a leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain. Using proprietary drug targets and state-of-the-art chemistry, the company is developing medicines that are designed to alleviate pain associated with trauma, operative procedures, and debilitating diseases such as arthritis, diabetes and multiple sclerosis. Ionix Pharmaceuticals is a privately held company and was founded in 2001.

About IDBS
IDBS works with discovery organisations to maximise the value of research data, by providing software solutions to capture, manage and use biological and chemical information in an integrated framework. IDBS delivers complete – and proven – applications that bridge the gap between IT and science. Headquartered in Guildford, United Kingdom, IDBS has offices in Emeryville, California; Parsippany, New Jersey; and, Cambridge, Massachusetts. IDBS partners with CTC Laboratory Systems in Japan to market IDBS products and services. Founded in 1989, IDBS employs over 150 people worldwide.

Media Contacts

Beth Thomas, Marketing Communications Manager
IDBS, 2 Occam Court, Surrey Research Park
Guildford, Surrey GU2 7QB, UK
Tel: +44 (0) 1483 595010
Fax: +44 (0) 1483 595001
Email: bthomas@id-bs.com

Andrew Sandham
President & CEO
Ionix Pharmaceuticals
Tel: +44 (0)1223 433 721